Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-28 | Amended | $124,105,981 | $44,106,077 | Equity Only | 06b | SEC link |
| 2022-10-03 | New | $79,999,904 | $79,999,904 | Equity Only | 06b | SEC link |
| 2021-02-12 | New | $18,834,498 | $18,834,498 | Equity Only | 06b | SEC link |
| 2019-12-19 | New | $5,302,511 | $5,302,511 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Vineeta Agarwala | Director |
| Robert Chess | Director |
| Mark De Pristo | Director, Executive |
| Francisco Gimenez | Director |
| Peyton Greenside | Director, Executive |
| Steve Kafka | Director |
| Theresa Tribble | Promoter |